22/03/2017: Call for experts in anonymisation of clinical data
The European Medicines Agency (EMA) has launched a call for applications to join a technical anonymisation group (TAG) with a broad range of expertise that will help EMA to further develop best practices for the anonymisation of clinical reports.
Individuals interested in becoming members of the TAG should send their CV and the declaration of interests form to firstname.lastname@example.org by 28/04/2017.
For more information see EMA website.
20/03/2017: Clinical data for two new medicines published
Palonosetron Accord is a generic medicine used to prevent nausea and vomiting caused by chemotherapy.
Amlodipine/Valsartan Mylan is a generic medicine used in patients who have essential hypertension (high blood pressure) that is not adequately controlled on either amlodipine or valsartan taken alone.